154 related articles for article (PubMed ID: 6206270)
1. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
[TBL] [Abstract][Full Text] [Related]
2. Localization of a normal prostatic secretory product using the monoclonal antibody KR-P8.
Raynor RH; Mohanakumar T; Moncure CW; Hazra TA
J Urol; 1985 Aug; 134(2):384-7. PubMed ID: 2410635
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
[TBL] [Abstract][Full Text] [Related]
5. Human prostate tissue antigens defined by murine monoclonal antibodies.
Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
10. Biochemical nature of the prostate-associated antigen identified by the monoclonal antibody, KR-P8.
Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
Prostate; 1986; 9(1):21-31. PubMed ID: 2426689
[TBL] [Abstract][Full Text] [Related]
11. [A monoclonal antibody that reacts with an antigen on both normal and malignant prostate cells].
Dou L; Yu L; Xing N; Ding Y; Deng F; Guo Y
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):234-6, 44. PubMed ID: 11825376
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
Lopes AD; Davis WL; Rosenstraus MJ; Uveges AJ; Gilman SC
Cancer Res; 1990 Oct; 50(19):6423-9. PubMed ID: 1698122
[TBL] [Abstract][Full Text] [Related]
14. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
15. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
16. In vivo localization of human colon adenocarcinoma by monoclonal antibody binding to a highly expressed cell surface antigen.
Takahashi H; Wilson B; Ozturk M; Motté P; Strauss W; Isselbacher KJ; Wands JR
Cancer Res; 1988 Nov; 48(22):6573-9. PubMed ID: 2460225
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
[TBL] [Abstract][Full Text] [Related]
18. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
19. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
Khan A; Grammer S; Chang D; Hill NO; Miller J
Cancer Res; 1983 Dec; 43(12 Pt 1):5868-72. PubMed ID: 6196109
[TBL] [Abstract][Full Text] [Related]
20. Measurement of prostate-specific membrane antigen in the serum with a new antibody.
Murphy GP; Tino WT; Holmes EH; Boynton AL; Erickson SJ; Bowes VA; Barren RJ; Tjoa BA; Misrock SL; Ragde H; Kenny GM
Prostate; 1996 Apr; 28(4):266-71. PubMed ID: 8602402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]